Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) had its price target raised by analysts at Needham & Company LLC from $16.00 to $18.00. They now have a "buy" rating on the stock.
Topical Drug Delivery Market Size to Hit USD 229.91 Bn by 2031 [Yahoo! Finance]
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) had its price target raised by analysts at Mizuho from $17.00 to $18.00. They now have a "buy" rating on the stock.
Arcutis Announces First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Arcutis Announces First Quarter 2024 Financial Results and Provides Business Update